Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1147420220070010001
Journal of Surgical Infection
2022 Volume.7 No. 1 p.1 ~ p.8
Review of Immunocompromised Patient Management to Prevent Surgical Site Infection
Ihn Myong-Hoon

Abstract
Surgical site infection (SSI) is defined by the United States Centers for Disease Control and Prevention as infection related to an operative procedure that occurs near or at the surgical incision site, deeper underlying tissue spaces and organs within 30 days of the procedure or within 90 days if prosthetic material is implanted at surgery. The prevention of SSI is increasingly important as the number of surgical procedures performed worldwide continues to rise. Immunocompromised patients are at higher risk of SSI and wound complications in both general and emergency surgery. Immunosuppressed state, in fact, and wound healing-impairing drugs assumption additionally increase the risk of infection. However, optimal management to prevent SSI in immunocompromised patients is not well established. Therefore, this article aims to review the best intervention to optimize wound management and minimize complications after surgery in immunocompromised patients through a review
of the literature.
KEYWORD
Immunocompromised host, Surgical site infection
FullTexts / Linksout information
Listed journal information